CareDx, Inc. — Form 8-K
Filed October 29, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 68/100
What the filing says
CareDx reported Q3 2026 revenue of $139M (+39% YoY), including $119M testing services revenue (+65% YoY) from the July 1, 2026 acquisition of Naveris, Inc. (NavDx) for $160M cash plus up to $100M contingent consideration. The company raised full-year 2026 revenue guidance to $520–$530M (prior: $490–$500M) and adjusted EBITDA guidance to $90–$100M (prior: $66–$78M). Q3 adjusted EBITDA reached $30M (22% margin) versus $15M in Q3 2025.
Why this rating
NavDx acquisition (~16% of company market cap) materially expands addressable market and shows strong integration; elevated guidance reflects confidence but contingent earn-out risk remains material.
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.